Tarceva 150 mg Tablet

उत्पाद विवरण

Tarceva 150 mg tablet is a targeted therapy designed for patients battling specific forms of cancer, particularly non-small cell lung cancer (NSCLC) and pancreatic cancer. This innovative medication works by inhibiting the action of epidermal growth factor receptor (EGFR) tyrosine kinase, which plays a crucial role in the growth and spread of cancer cells. By blocking this pathway, Tarceva helps slow down tumor progression and can improve overall survival rates in affected individuals. It is essential to use Tarceva under the guidance of a healthcare professional, as it may lead to side effects such as skin rash, diarrhea, and liver function changes. Patients should also be aware of potential drug interactions and should inform their doctors about any other medications they are taking. Regular monitoring is recommended during treatment to manage any adverse effects effectively. With its focused approach, Tarceva 150 mg offers hope to those facing challenging cancer diagnoses, making it a vital option in modern oncology. Always consult with your healthcare provider to determine if Tarceva is the right choice for your treatment plan.